About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
1,980.5
JPY
+43.5
(+2.25%)
May 1, 12:55 pm JST
13.77
USD
Apr 30, 11:55 pm EDT
Result
PTS
outside of trading hours
1,981.6
May 1, 12:54 pm JST
Summary Chart Historical News Financial Result
PER
17.0
PBR
4.52
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
May 1, 2025
Opening May 1, 9:00 am
1,951.0 JPY 13.64 USD
Previous Close Apr 30
1,937.0 JPY 13.58 USD
High May 1, 10:04 am
1,998.0 JPY 13.96 USD
Low May 1, 9:01 am
1,941.5 JPY 13.58 USD
Volume
259,800
Trading Value
0.52B JPY 3.58M USD
VWAP
1981.56 JPY 13.79 USD
Minimum Trading Value
198,050 JPY 1,377 USD
Market Cap
0.26T JPY 1.80B USD
Number of Trades
1,214
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
High
1-Year Average
3,372
1-Year High Feb 14, 2025
14,693
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 69,400 1,161,500 16.74
Apr 18, 2025 51,100 1,165,100 22.80
Apr 11, 2025 40,600 1,132,000 27.88
Apr 4, 2025 18,700 1,316,400 70.40
Mar 28, 2025 37,700 1,426,100 37.83
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.